Left ventricular hypertrophy in Turner syndrome: A prospective echocardiographic study

Echocardiography

Volumn 29, Issue 9, 2012, Pages 1022-1030

  Mortensen, Kristian Havmand ^a,b   Gravholt, Claus Højbjerg ^a   Hjerrild, Britta Eilersen ^a   Stochholm, Kirstine ^a   Andersen, Niels Holmark ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

bicuspid aortic valve; cardiac imaging; cardiomyopathy; congenital heart disease; hypertension; left ventricular hypertrophy

Indexed keywords

ADULT; BICUSPID AORTIC VALVE; BLOOD PRESSURE; BODY SURFACE; ECHOCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TURNER SYNDROME;

ADULT; AGED; COMORBIDITY; DENMARK; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TURNER SYNDROME; YOUNG ADULT;

EID: 84867404510     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2012.01754.x     Document Type: Review

References (37)

1. Stochholm K, Juul S, Juel K, et al,: Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006; 91: 3897-3902.
2. Schoemaker MJ, Swerdlow AJ, Higgins CD, et al,: Mortality in women with turner syndrome in Great Britain: A national cohort study. J Clin Endocrinol Metab 2008; 93: 4735-4742.
3. Gravholt CH, Juul S, Naeraa RW, et al,: Morbidity in Turner syndrome. J Clin Epidemiol 1998; 51: 147-158.
4. Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al,: Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiol Young 2006; 16: 430-436.
5. Price WH, Clayton JF, Collyer S, et al,: Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986; 40: 97-102.
6. Carlson M, Silberbach M,: Dissection of the aorta in Turner syndrome: Two cases and review of 85 cases in the literature. J Med Genet 2007; 44: 745-749.
7. Levy D, Garrison RJ, Savage DD, et al,: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
8. Sozen AB, Cefle K, Kudat H, et al,: Left ventricular thickness is increased in nonhypertensive Turner's syndrome. Echocardiography 2009; 26: 943-949.
9. Tancredi G, Versacci P, Pasquino AM, et al,: Cardiopulmonary response to exercise and cardiac assessment in patients with turner syndrome. Am J Cardiol 2011; 107: 1076-1082.
10. Andersen NH, Hjerrild BE, Sorensen K, et al,: Subclinical left ventricular dysfunction in normotensive women with Turner's syndrome. Heart 2006; 92: 1516-1517.
11. Sachdev V, Matura LA, Sidenko S, et al,: Aortic valve disease in Turner syndrome. J Am Coll Cardiol 2008; 51: 1904-1909.
12. Mortensen KH, Hjerrild BE, Andersen NH, et al,: Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging. Cardiol Young 2010; 20: 191-200.
13. Ostberg JE, Brookes JA, McCarthy C, et al,: A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004; 89: 5966-5971.
14. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L,: Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001; 86: 4166-4170.
15. Trolle C, Hjerrild B, Cleemann L, et al,: Sex hormone replacement in Turner syndrome. Endocrine 2011; 41: 200-219.
16. Bondy CA,: Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007; 92: 10-25.
17. Kikuya M, Hansen TW, Thijs L, et al,: Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115: 2145-2152.
18. Lang RM, Bierig M, Devereux RB, et al,: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
19. Wachtell K, Smith G, Gerdts E, et al,: Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol 2000; 85: 466-472.
20. Mortensen KH, Hjerrild BE, Stochholm K, et al,: Dilation of the ascending aorta in Turner syndrome-A prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2011; 13: 24.
21. Mancia G, Laurent S, Agabiti-Rosei E, et al,: Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158.
22. Vahanian A, Baumgartner H, Bax J, et al,: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
23. Ostberg JE, Storry C, Donald AE, et al,: A dose-response study of hormone replacement in young hypogonadal women: Effects on intima media thickness and metabolism. Clin Endocrinol(Oxf) 2007; 66: 557-564.
24. Host C, Bojesen A, Frystyk J, et al,: Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome. Eur J Clin Invest 2010; 40: 211-219.
25. Chan NN, Vallance P, Colhoun HM, et al,: The effects of hormone replacement therapy on endothelial function in women with Turner's syndrome. ClinEndocrinol(Oxf) 2002; 56: 615-620.
26. Papagianni V, Deligeoroglou E, Makrakis E, et al,: Response to hormonal treatment of young females with primary or very premature ovarian failure. Gynecol Endocrinol 2011; 27: 291-299.
27. Gravholt CH, Naeraa RW, Nyholm B, et al,: Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998; 21: 1062-1070.
28. Mendelsohn ME, Karas RH,: Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308: 1583-1587.
29. Turgeon JL, Carr MC, Maki PM, et al,: Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev 2006; 27: 575-605.
30. Sozen AB, Cefle K, Kudat H, et al,: Atrial and ventricular arryhthmogenic potential in Turner Syndrome. Pacing Clin Electrophysiol 2008; 31: 1140-1145.
31. Benjamin EJ, D'Agostino RB, Belanger AJ, et al,: Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995; 92: 835-841.
32. Kuhl JT, Moller JE, Kristensen TS, et al,: Left atrial function and mortality in patients with NSTEMI an MDCT study. JACC Cardiovasc Imaging 2011; 4: 1080-1087.
33. Lai CL, Chien KL, Hsu HC, et al,: Left atrial dimension and risk of stroke in women without atrial fibrillation: The Chin-Shan Community Cardiovascular Cohort study. Echocardiography 2011; 28: 1054-1060.
34. Mor-Avi V, Lang RM, Badano LP, et al,: Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 2011; 12: 167-205.
35. Gravholt CH, Juul S, Naeraa RW, et al,: Prenatal and postnatal prevalence of Turner's syndrome: A registry study. BMJ 1996; 312: 16-21.
36. Ho VB, Bakalov VK, Cooley M, et al,: Major vascular anomalies in Turner syndrome: Prevalence and magnetic resonance angiographic features. Circulation 2004; 110: 1694-1700.
37. Hjerrild BE, Mortensen KH, Gravholt CH,: Turner syndrome and clinical treatment. Br Med Bull 2008; 86: 77-93.